Methyl 3-amino-5-bromo-2-benzofurancarboxylate, 95+%, 5g

(1-Cyano-2-ethoxy-2-oxoethylidene aminooxy)dimethylaminomorpholino carbenium hexafluorophosphate, 98.0%, 25g

(2E)-3-(4'-Hydroxy-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl)-2-propenoic acid, 98%, 250mg

(5-Bromo-2-chloropyridin-3-yl)boronic acid, 95.0%, 5g

Ethyl 8-methyl-6-nitroimidazo[1,2-a]pyridine-2-carboxylate, 98%, 1g

(S)-2-(4-Methoxy-6-methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole, 98%, 100mg

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoate, 97.0%, 100mg

(2S,3R)-3-Amino-2-hydroxy-4-phenyl-butyric acid, 98.0%, 10g

Solution étalon de platine ICP, ROTI®Star, 250 ml, LDPE

(Z)-2-(2-Aminothiazol-4-yl)-2-(((1-(tert-butoxy)-2-methyl-1-oxopropan-2-yl)oxy)imino)acetic acid, 95.0%, 25g

2-Methyl-3-nitroaniline>98.0%(GC)25g

8-Methoxy-1,2,3,4-tetrahydroisoquinoline, 95.0%, 1g

Ethyl 5-amino-6-bromo-2-methylnicotinate, 95+%, 10g